Cortagen
What do these badges mean?
Evidence tier
- AHuman-validated — Human trials showing positive results and good safety.
- BAnimal-grade — No human trials yet, but solid animal/preclinical evidence of effect and safety.
- CAnecdotal — No human or animal trials — only anecdotal/observational reports.
- DInsufficient evidence — No or insufficient evidence (encyclopedia only — never recommended by the builder).
Safety light
- 🟢 Green — Only mild, manageable side effects; reasonable safety data.
- 🟡 Yellow — Needs active management, has a meaningful contraindication/interaction, or has thin long-term data.
- 🔴 Red — Risk of a hospital-level event — treat with serious caution.
Browse-only — not on the protocol builder's curated shortlist, so the builder won't recommend it.
What is it?
Cortagen is a synthetic Khavinson tetrapeptide: sequence Ala-Glu-Asp-Pro (AEDP). It’s one of approximately 15 organ-targeted peptides in the Khavinson bioregulator family (alongside Pinealon, Epithalon, Vilon, Thymalin, Cortexin, etc.), from the same Khavinson group / St. Petersburg Institute of Bioregulation and Gerontology lineage.
The Khavinson framework, in brief. Cortagen shares its origin story with sibling peptide Pinealon: a 1970s Soviet military-medicine research program at the Military Medical Academy in Leningrad extracted tissue-specific peptide fractions from organs and observed bioactive effects when re-administered. The theoretical claim is that short peptides (2-4 amino acids) cross cell + nuclear membranes → bind specific DNA promoter regions → modulate transcription in a tissue-specific way, with each peptide’s sequence claimed to reproduce a fragment originally extracted from its target organ tissue. Cortagen’s tissue specificity is cortical neurons. Western reception is split — conventional Western view: preclinical-only, single-research-group, weak methodology, heterodox mechanism; Russian/Eastern European view: a 50-year sustained research program with consistent reported outcomes and several sibling peptides (Cortexin, Thymalin) approved for clinical use in Russia. OHM’s lean: report both perspectives honestly.
What does it do in my body?
Same Khavinson framework as Pinealon and Epithalon: cross cell and nuclear membranes, bind specific DNA promoter sequences, modulate transcription in a tissue-specific way — Cortagen’s tissue specificity is cortical neurons.
Operational distinction vs. Semax / Selank:
- Semax → acute receptor-mediated signaling (MC4/MC3 → BDNF/NGF transcription; fast onset, days).
- Selank → acute multi-pathway modulation (BDNF + enkephalin + monoamine; fast onset, days).
- Cortagen → claimed gene-expression modulation → effects develop over a 10-20 day cycle and are claimed to persist 2-3 months after the cycle ends. Slow-onset, long-tail mechanism if the Khavinson framework holds.
How can it help me?
- Where the science stands: Animal (Morris water maze, hippocampal BDNF, oxidative neuroprotection) + unblinded Russian post-stroke human clinical data; no Western RCTs
The full evidence — every human, animal, and lab study, graded — is one tap away: use the See the deeper science → toggle at the top.
Is it dangerous? What are the side effects?
- Infrequent local injection-site reactions; transient mild headache early in the cycle.
- No serious AEs documented at standard doses in the Russian literature.
- Counterfeiting risk is real — flagged across multiple sources for this peptide specifically. A verified-COA vendor is essential.
- Long-term repeated-cycle safety in humans is not characterized in Western pharmacovigilance.
Regulatory status: Not FDA-approved. No Western RCTs; long clinical-use history in Russia under Khavinson-school protocols, including unblinded post-stroke cognitive-recovery studies.
Where to buy. Cortagen is not in Alyve’s current launch catalog, but it is available through BioLongevity — use code OHM-15 (BioLongevity shares Alyve’s coupon code) for 15% off. Given the counterfeiting risk flagged above for this peptide specifically, a third-party-COA, identity-confirmed product matters disproportionately.
Part 1 — How to reconstitute it
What you'll need: bacteriostatic water (sterile, preserved water you mix the powder with) and a separate, larger reconstitution syringe just for mixing — not the small syringe you inject with.
Storage: Lyophilized at -20°C is stable 2+ years; reconstituted (bacteriostatic water with 0.9% benzyl alcohol) refrigerate at 2-8°C and discard at 28 days.
How to mix it
- Tilt the vial and let the bacteriostatic water run slowly down the inside glass wall — never squirt it straight onto the powder.
- Swirl gently to dissolve. Never shake — shaking can damage the peptide.
- Store the reconstituted vial refrigerated and out of light.
- Use it within the beyond-use window your source specifies — reconstituted peptides are commonly used within a few weeks; confirm the window for your specific peptide.
Use the free reconstitution calculator to turn any vial size + water volume into exact units on an insulin syringe.
Part 2 — Typical dosing
Talk to your medical provider before starting any protocol. That said, here are the doses most people commonly use — shared for educational purposes so you can have an informed conversation. These peptides are sold for research use only and are not FDA-approved drugs, and this isn't medical advice.
The syringe. Use a 0.3 mL U-100 insulin syringe — it's sized for these small subcutaneous doses. Inject subcutaneously (into the fat just under the skin) and rotate injection sites.
Cortagen has more route variety than most peptides — it’s available as SubQ injection, IM injection, sublingual drops, and oral capsule, with different protocols for each:
| Context | Dose | Route | Duration | Frequency |
|---|---|---|---|---|
| Cognitive / nootropic | 200-400 mcg | SubQ | 10-20 days | 2-3×/year |
| Post-TBI / post-stroke (Russian clinical) | 2-10 mg | IM | 5-10 days | Per neurologist |
| Sublingual retail | 3-4 drops | SL | 30 days | 3×/year |
| Oral capsule retail | 2 daily | PO | 30 days cycled | 3-4×/year |
Cycling philosophy. Like sibling Khavinson peptides, Cortagen is run in short cycles (10-20 days), spaced across the year, rather than continuously — the claimed 2-3 month post-cycle persistence is the rationale for the pulse-and-rest pattern rather than daily maintenance dosing. This is the same cycled-bioregulator shape documented for Pinealon and Epithalon.
Turning milligrams into syringe units. On a U-100 syringe, 100 units = 1 mL, so 1 unit = 0.01 mL. At a concentration of C mg/mL, a dose of D mg = D ÷ C mL = (D ÷ C) × 100 units. Example: at 5 mg/mL, a 0.5 mg dose = 0.1 mL = 10 units. Your exact units depend on your own vial's mg and how much bacteriostatic water you added — use the same concentration you mixed above.
What should I avoid combining — and what's synergistic?
Cortagen doesn't have a dedicated stacking protocol in our notes — the interactions that matter most are in the safety section above. For how people combine it with other peptides, the deeper-science view has the full detail.
How can I buy this?
Cortagen is available from BioLongevity Labs — use code OHM-15 at BioLongevity for 15% off. As always, buy only from a source that publishes third-party Certificates of Analysis (COAs) confirming identity and >99% purity.
When you use my coupon code to buy peptides with these sellers, you enjoy a discount off retail price, and I make a small commission which helps me to continue to offer this peptide educational site to you for free. I only have affiliate relationships with peptide manufacturers that show evidence that their peptides are 100% manufactured in the US, 3rd party lab tested for purity, transparent COAs posted on their websites, and that have good customer service.
A synthetic Khavinson-school tetrapeptide targeted to cortical neurons — a slow-onset, cycle-based cognitive bioregulator with a real (if methodologically weak by Western standards) Russian post-stroke clinical record.
| Class | Khavinson tetrapeptide (short-peptide bioregulator) |
| Sequence | Ala-Glu-Asp-Pro (AEDP) |
| Mechanism (one line) | Claimed DNA-promoter binding in cortical neurons → slow-onset gene-expression modulation, effects claimed to persist 2-3 months post-cycle |
| Evidence base | Animal (Morris water maze, hippocampal BDNF, oxidative neuroprotection) + unblinded Russian post-stroke human clinical data; no Western RCTs |
| Safety record | No serious AEs documented at standard doses in the Russian literature; long-term repeated-cycle safety not characterized in Western pharmacovigilance |
| Regulatory status | Not FDA-approved; counterfeiting risk flagged for this peptide specifically |
What it is
Cortagen is a synthetic Khavinson tetrapeptide: sequence Ala-Glu-Asp-Pro (AEDP). It’s one of approximately 15 organ-targeted peptides in the Khavinson bioregulator family (alongside Pinealon, Epithalon, Vilon, Thymalin, Cortexin, etc.), from the same Khavinson group / St. Petersburg Institute of Bioregulation and Gerontology lineage.
The Khavinson framework, in brief. Cortagen shares its origin story with sibling peptide Pinealon: a 1970s Soviet military-medicine research program at the Military Medical Academy in Leningrad extracted tissue-specific peptide fractions from organs and observed bioactive effects when re-administered. The theoretical claim is that short peptides (2-4 amino acids) cross cell + nuclear membranes → bind specific DNA promoter regions → modulate transcription in a tissue-specific way, with each peptide’s sequence claimed to reproduce a fragment originally extracted from its target organ tissue. Cortagen’s tissue specificity is cortical neurons. Western reception is split — conventional Western view: preclinical-only, single-research-group, weak methodology, heterodox mechanism; Russian/Eastern European view: a 50-year sustained research program with consistent reported outcomes and several sibling peptides (Cortexin, Thymalin) approved for clinical use in Russia. OHM’s lean: report both perspectives honestly.
How it works
Same Khavinson framework as Pinealon and Epithalon: cross cell and nuclear membranes, bind specific DNA promoter sequences, modulate transcription in a tissue-specific way — Cortagen’s tissue specificity is cortical neurons.
Operational distinction vs. Semax / Selank:
- Semax → acute receptor-mediated signaling (MC4/MC3 → BDNF/NGF transcription; fast onset, days).
- Selank → acute multi-pathway modulation (BDNF + enkephalin + monoamine; fast onset, days).
- Cortagen → claimed gene-expression modulation → effects develop over a 10-20 day cycle and are claimed to persist 2-3 months after the cycle ends. Slow-onset, long-tail mechanism if the Khavinson framework holds.
What the research shows
- Animal data: Rodent + aging-rat studies showing improved Morris water maze performance, increased hippocampal BDNF expression, oxidative neuroprotection PMIDs.
- Human data: Russian post-stroke clinical studies showing cognitive improvement — lack blinded design; methodologically weak by Western RCT standards. The clinical signal is interesting; the trial design is not what a Western reviewer would accept as proof.
- Key references: Khavinson + Kuznik Peptide Bioregulators monograph (2014); Khavinson Peptides and Ageing (PubMed).
- No Western RCTs.
0035 categorization pass grade: C/green (cognitive cluster).
Real-world protocol
The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.
Cortagen has more route variety than most peptides — it’s available as SubQ injection, IM injection, sublingual drops, and oral capsule, with different protocols for each:
| Context | Dose | Route | Duration | Frequency |
|---|---|---|---|---|
| Cognitive / nootropic | 200-400 mcg | SubQ | 10-20 days | 2-3×/year |
| Post-TBI / post-stroke (Russian clinical) | 2-10 mg | IM | 5-10 days | Per neurologist |
| Sublingual retail | 3-4 drops | SL | 30 days | 3×/year |
| Oral capsule retail | 2 daily | PO | 30 days cycled | 3-4×/year |
Storage: Lyophilized at -20°C is stable 2+ years; reconstituted (bacteriostatic water with 0.9% benzyl alcohol) refrigerate at 2-8°C and discard at 28 days.
Cycling philosophy. Like sibling Khavinson peptides, Cortagen is run in short cycles (10-20 days), spaced across the year, rather than continuously — the claimed 2-3 month post-cycle persistence is the rationale for the pulse-and-rest pattern rather than daily maintenance dosing. This is the same cycled-bioregulator shape documented for Pinealon and Epithalon.
Side effects & management
- Infrequent local injection-site reactions; transient mild headache early in the cycle.
- No serious AEs documented at standard doses in the Russian literature.
- Counterfeiting risk is real — flagged across multiple sources for this peptide specifically. A verified-COA vendor is essential.
- Long-term repeated-cycle safety in humans is not characterized in Western pharmacovigilance.
Regulatory status
Not FDA-approved. No Western RCTs; long clinical-use history in Russia under Khavinson-school protocols, including unblinded post-stroke cognitive-recovery studies.
Where to buy. Cortagen is not in Alyve’s current launch catalog, but it is available through BioLongevity — use code OHM-15 (BioLongevity shares Alyve’s coupon code) for 15% off. Given the counterfeiting risk flagged above for this peptide specifically, a third-party-COA, identity-confirmed product matters disproportionately.
Technical & analytical reference (chemistry & QC)
| Field | Value |
|---|---|
| Molecular formula | C17H26N4O9 |
| Average MW | 430.41 g/mol — some sources give C18H27N5O9 / 457.43, which is wrong; the authoritative tetrapeptide (Ala-Glu-Asp-Pro) formula is C17H26N4O9 / avg MW 430.41 |
| CAS | none established |
| Sequence | Ala-Glu-Asp-Pro (AEDP) |
| PubChem CID | not established in current sourcing |
Sources
- primary source for mechanism claims, dosing protocols, the Khavinson framework context, and the comparison against Semax/Selank.
- baseline grading (C/green ).
- Migrated from
cognitive-peptides-cluster.md(retired) — 2026-07-16.
Related: Pinealon · Dihexa · Epithalon · Semax · Selank · the Khavinson bioregulator family.
Sources & references
- primary source for mechanism claims, dosing protocols, the Khavinson framework context, and the comparison against Semax/Selank.
- baseline grading (C/green ).
- Migrated from
cognitive-peptides-cluster.md(retired) — 2026-07-16.
Related: Pinealon · Dihexa · Epithalon · Semax · Selank · the Khavinson bioregulator family.